IceCure Medical (ICCM) Stock Price, News & Analysis

+0.02 (+1.96%)
(As of 05/17/2024 ET)
Today's Range
50-Day Range
52-Week Range
137,228 shs
Average Volume
222,674 shs
Market Capitalization
$47.44 million
P/E Ratio
Dividend Yield
Price Target

IceCure Medical MarketRank™ Stock Analysis

Analyst Rating
3.00 Rating Score
183.7% Upside
$2.95 Price Target
Short Interest
1.39% of Float Sold Short
Dividend Strength
News Sentiment
0.04mentions of IceCure Medical in the last 14 days
Based on 2 Articles This Week
Insider Trading
Proj. Earnings Growth
From ($0.28) to ($0.27) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.24 out of 5 stars

Medical Sector

521st out of 921 stocks

Surgical & Medical Instruments Industry

62nd out of 96 stocks

ICCM stock logo

About IceCure Medical Stock (NASDAQ:ICCM)

IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a single probe system for the treatment of breast tumors; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

ICCM Stock Price History

ICCM Stock News Headlines

IceCure Medical (NASDAQ:ICCM) Shares Down 3.3%
Hofseth Biocare ASA: HBC ANNUAL REPORT 2023
See More Headlines
Receive ICCM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IceCure Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Surgical & medical instruments
Current Symbol
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
2 Analysts


Net Income
Net Margins
Pretax Margin


Sales & Book Value

Annual Sales
$3.23 million
Book Value
$0.27 per share


Free Float
Market Cap
$47.44 million
Not Optionable
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Mr. Eyal Shamir (Age 63)
    CEO & Director
    Comp: $416.36k
  • Mr. Ronen Tsimerman CPA (Age 55)
    CFO & COO
    Comp: $306.4k
  • Ms. Tlalit Bussi Tel-Tzure (Age 53)
    Vice President of Business Development & Global Marketing
    Comp: $248.44k
  • Ms. Merav Nir Dotan (Age 55)
    Vice President of Human Resources
    Comp: $197.96k
  • Ms. Galit Malik (Age 51)
    Vice President of Operations & Service

ICCM Stock Analysis - Frequently Asked Questions

Should I buy or sell IceCure Medical stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for IceCure Medical in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" ICCM shares.
View ICCM analyst ratings
or view top-rated stocks.

What is IceCure Medical's stock price target for 2024?

2 analysts have issued 1 year target prices for IceCure Medical's shares. Their ICCM share price targets range from $2.90 to $3.00. On average, they anticipate the company's stock price to reach $2.95 in the next twelve months. This suggests a possible upside of 183.7% from the stock's current price.
View analysts price targets for ICCM
or view top-rated stocks among Wall Street analysts.

How have ICCM shares performed in 2024?

IceCure Medical's stock was trading at $1.07 at the beginning of the year. Since then, ICCM stock has decreased by 2.8% and is now trading at $1.04.
View the best growth stocks for 2024 here

When is IceCure Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 27th 2024.
View our ICCM earnings forecast

How were IceCure Medical's earnings last quarter?

IceCure Medical Ltd (NASDAQ:ICCM) released its earnings results on Wednesday, April, 3rd. The company reported ($0.07) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.08) by $0.01. The business earned $1.26 million during the quarter. IceCure Medical had a negative net margin of 453.76% and a negative trailing twelve-month return on equity of 86.96%. During the same period in the prior year, the company posted ($0.11) earnings per share.

How do I buy shares of IceCure Medical?

Shares of ICCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ICCM) was last updated on 5/18/2024 by Staff

From Our Partners